Scientists map genetic basis of phage resistance in antibiotic-resistant bacteria

Mycobacterium abscessus is a bacterium that grows quickly and resists most antibiotics—a combination that leaves doctors with few options when infection takes hold. The organism exists in two distinct forms inside the human body, smooth and rough variants, each contributing to the disease in different ways. As conventional drugs fail, phage therapy—using viruses that attack bacteria—has emerged as a potential last resort. Yet until now, scientists have not fully understood how these phages actually attach to and infect M. abscessus at the genetic level, a gap that has limited the ability to design therapies that would hold up over time.

Researchers working with clinical isolates of both bacterial morphotypes set out to map this interaction. They developed novel phages capable of infecting both forms of the bacterium, then studied what happened when the bacteria evolved resistance. Using whole-genome sequencing, gene expression analysis, and direct measurements of phage attachment, they traced the genetic changes that allowed bacteria to evade infection. The work confirmed that a surface molecule called trehalose polyphleate acts as a receptor that phages use to latch onto the bacterial cell—a finding that held true across both morphotypes. But the story did not end there.

The team identified a large stretch of the bacterial genome containing more than ten genes that also control phage susceptibility, along with two additional genes named furB and nrnA. When bacteria accumulated mutations in these regions, they consistently became resistant to phage infection. The mechanism was consistent: every resistant variant showed impaired phage attachment, suggesting these genes encode or regulate the very surface structures that phages need to grab hold of the cell.

Functional analysis revealed the deeper pattern. The genes involved in resistance were not random; they clustered around bacterial lipid metabolism—the cellular machinery that builds and maintains the fatty molecules that form the bacterial membrane. Some resistant bacteria carried mutations in lipid-associated genes scattered across that large genomic region, each producing a distinct lipid profile. Others had frameshift mutations in furB or nrnA that triggered a cascade of changes in how lipid-related genes were expressed throughout the cell. In each case, the altered lipid composition prevented phages from attaching.

The finding reframes how researchers should think about phage-bacteria interactions in mycobacteria. Previous studies had hinted that surface molecules mattered; this work extends that insight by identifying specific genetic switches and metabolic pathways that tune the bacterial membrane in ways that either permit or block phage entry. The researchers acknowledge that direct proof of causation remains elusive—testing these genes in clinical strains of M. abscessus is technically demanding and ethically fraught. Yet the genetic framework they have constructed provides a foundation for understanding why some bacteria escape phage infection and, more importantly, where to look when designing therapies meant to last. As phage-based treatments move toward clinical use, knowing which genes bacteria will likely mutate, and what cellular systems those genes control, offers a roadmap for engineering more durable weapons against one of medicine's most stubborn adversaries.